Decreased levels of sCD21 and sCD23 in blood of patients with systemic-juvenile arthritis, polyarticular-juvenile arthritis, and pauciarticular-juvenile arthritis

Rheumatology International

Volumn 32, Issue 6, 2012, Pages 1581-1587

  Singh, Anjana ^a   Vastert, Sebastiaan J ^b   Prakken, Berent J ^b   Illges, Harald ^a  

^a UNIVERSITY OF APPLIED SCIENCES   (Germany)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Complement; Juvenile arthritis (JA); Soluble CD21; Soluble CD23

Indexed keywords

BIOLOGICAL MARKER; CD23 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; SOLUBLE CD21 ANTIGEN; SOLUBLE CD23 ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNE DISEASE; CELL COUNT; CELL DIFFERENTIATION; CLINICAL ASSESSMENT; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; PAUCIARTICULAR JUVENILE ARTHRITIS; POLYARTICULAR JUVENILE ARTHRITIS; PRIORITY JOURNAL; SYSTEMIC JUVENILE ARTHRITIS;

ADOLESCENT; AGE FACTORS; ARTHRITIS, JUVENILE RHEUMATOID; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFANT; INFANT, NEWBORN; RECEPTORS, COMPLEMENT 3D; RECEPTORS, IGE; UP-REGULATION;

EID: 84863860166     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-1830-1     Document Type: Article

References (38)

1. Gare BA (1998) Epidemiology. Baillieres Clin Rheumatol 12(2):191-208
2. Panayi GS, Corrigall VM, Pitzalis C (2001) Pathogenesis of rheumatoid arthritis. The role of T cells and other beasts. Rheum Dis Clin North Am 27(2):317-334
3. Edwards JC, Cambridge G, Abrahams VM (1999) Do self-perpetuating B lymphocytes drive human autoimmune disease? Immunology 97(2):188-196
4. Edwards JC, Cambridge G (2001) Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology (Oxford) 40(2):205-211
5. Aggarwal A, Bhardwaj A, Alam S, Misra R (2000) Evidence for activation of the alternate complement pathway in patients with juvenile rheumatoid arthritis. Rheumatology (Oxford) 39(2):189-192
6. Miller JJ 3rd, Olds LC, Huene DB (1986) Complement activation products and factors infiuencing phagocyte migration in synovial fluids from children with chronic arthritis. Clin Exp Rheumatol 4(1):53-56
7. Ahearn JM, Fearon DT (1989) Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv Immunol 46:183-219
8. Tedder TF, Clement lt, Cooper MD (1984) Expression of C3d receptors during human B cell differentiation: immunoXuorescence analysis with the HB-5 monoclonal antibody. J Immunol 133(2):678-683
9. Reynes M, Aubert JP, Cohen JH, Audouin J, Tricottet V, Diebold J, Kazatchkine MD (1985) Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens. J Immunol 135(4):2687-2694
10. Fischer E, Delibrias C, Kazatchkine MD (1991) Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J Immunol 146(3):865-869
11. Larcher C, Schulz TF, Hofbauer J, Hengster P, Romani N, Wachter H, Dierich MP (1990) Expression of the C3d/EBV receptor and of other cell membrane surface markers is altered upon HIV-1 infection of myeloid, T, and B cells. J Acquir Immune DeWc Syndr 3(2):103-108
12. Delibrias CC, Fischer E, Bismuth G, Kazatchkine MD (1992) Expression, molecular association, and functions of C3 complement receptors CR1 (CD35) and CR2 (CD21) on the human T cell line HPB-ALL. J Immunol 149(3):768-774
13. Carroll MC, Prodeus AP (1998) Linkages of innate and adaptive immunity. Curr Opin Immunol 10(1):36-40
14. Fearon DT, Carroll MC (2000) Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu Rev Immunol 18:393-422
15. Masilamani M, Kassahn D, Mikkat S, Glocker MO, Illges H (2003) B cell activation leads to shedding of complement receptor type II (CR2/CD21). Eur J Immunol 33(9):2391-2397
16. Huemer HP, Larcher C, Prodinger WM, Petzer AL, Mitterer M, Falser N (1993) Determination of soluble CD21 as a parameter of B cell activation. Clin Exp Immunol 93(2):195-199
17. Singh A, Blank M, Shoenfeld Y, Illges H (2008) Antiphospholipid syndrome patients display reduced titers of soluble CD21 in their sera irrespective of circulating anti-beta2-glycoprotein-I autoantibodies. Rheumatol Int
18. Masilamani M, von Kempis J, Illges H (2004) Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis. Rheumatology (Oxford) 43(2):186-190
19. Illges H, Braun M, Peter HH, Melchers I (2000) Reduced expression of the complement receptor type 2 (CR2, CD21) by synovial fluid B and T lymphocytes. Clin Exp Immunol 122(2):270-276
20. Masilamani M, Nowack R, Witte T, Schlesier M, Warnatz K, Glocker MO, Peter HH, Illges H (2004) Reduction of soluble complement receptor 2/CD21 in systemic lupus erythomatosus and Sjoegren's syndrome but not juvenile arthritis. Scand J Immunol 60(6):625-630
21. Fremeaux-Bacchi V, Aubry JP, Bonnefoy JY, Kazatchkine MD, Kolb JP, Fischer EM (1998) Soluble CD21 induces activation and differentiation of human monocytes through binding to membrane CD23. Eur J Immunol 28(12):4268-4274
22. Delespesse G, Suter U, Mossalayi D, Bettler B, Sarfati M, Hofstetter H, Kilcherr E, Debre P, Dalloul A (1991) Expression, structure, and function of the CD23 antigen. Adv Immunol 49:149-191
23. Delespesse G, Sarfati M, Wu CY, Fournier S, Letellier M (1992) The low-affinity receptor for IgE. Immunol Rev 125:77-97
24. Sarfati M, Fournier S, Wu CY, Delespesse G (1992) Expression, regulation and function of human Fc epsilon RII (CD23) antigen. Immunol Res 11(3-4):260-272
25. Liu YJ, Cairns JA, Holder MJ, Abbot SD, Jansen KU, Bonnefoy JY, Gordon J, MacLennan IC (1991) Recombinant 25-kDa CD23 and interleukin 1 alpha promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur J Immunol 21(5):1107-1114
26. Masilamani M, Apell HJ, Illges H (2002) Purification and characterization of soluble CD21 from human plasma by affinity chromatography and density gradient centrifugation. J Immunol Methods 270(1):11-18
27. Sato S, Fujimoto M, Kikuchi K, Ihn H, Tamaki K, Takehara K (1996) Elevated soluble CD23 levels in the sera from patients with localized scleroderma. Arch Dermatol Res 288(2):74-78
28. Bansal A, Roberts T, Hay EM, Kay R, Pumphrey RS, Wilson PB (1992) Soluble CD23 levels are elevated in the serum of patients with primary Sjoegren's syndrome and systemic lupus erythematosus. Clin Exp Immunol 89(3):452-455
29. Del Nagro CJ, Kolla RV, Rickert RC (2005) A critical role for complement C3d and the B cell coreceptor (CD19/CD21) complex in the initiation of inflammatory arthritis. J Immunol 175(8):5379-5389
30. Bonnefoy JY, Lecoanet-Henchoz S, Aubry JP, Gauchat JF, Graber P (1995) CD23 and B-cell activation. Curr Opin Immunol 7(3):355-359
31. Cherukuri A, Cheng PC, Pierce SK (2001) The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens. J Immunol 167(1):163-172
32. Bjorck P, Elenstrom-Magnusson C, Rosen A, Severinson E, Paulie S (1993) CD23 and CD21 function as adhesion molecules in homotypic aggregation of human B lymphocytes. Eur J Immunol 23(8):1771-1775. doi:10.1002/eji.1830230806
33. Fujiwara H, Kikutani H, Suematsu S, Naka T, Yoshida K, Tanaka T, Suemura M, Matsumoto N, Kojima S et al (1994) The absence of IgE antibody-mediated augmentation of immune responses in CD23-deWcient mice. Proc Natl Acad Sci U S A 91(15):6835-6839
34. Reljic R, Cosentino G, Gould HJ (1997) Function of CD23 in the response of human B cells to antigen. Eur J Immunol 27(2):572-575 doi:10.1002/eji. 1830270232
35. Lecoanet-Henchoz S, Gauchat JF, Aubry JP, Graber P, Life P, Paul-Eugene N, Ferrua B, Corbi AL, Dugas B, Plater-Zyberk C et al (1995) CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity 3(1):119-125
36. Tanner J, Weis J, Fearon D, Whang Y, KieV E (1987) Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis. Cell 50(2):203-213. doi:0092-8674(87)90216-9
37. Weis JJ, Tedder TF, Fearon DT (1984) IdentiWcation of a 145, 000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc Natl Acad Sci U S A 81(3):881-885
38. Chen CY, Tsao CH, Ou LS, Yang MH, Kuo ML, Huang JL (2002) Comparison of soluble adhesion molecules in juvenile idiopathic arthritis between the active and remission stages. Ann Rheum Dis 61(2):167-170